Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Regimen
AddedFeb 16, 2024
UpdatedJun 18, 2026
Regimen

Regimen

Seed

Regimen: A CE-certified digital therapeutic program for long-term erectile dysfunction in men.

HQ
San Jose, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Regimen was founded with the mission to provide a holistic, digital therapeutic solution for men suffering from long-term erectile dysfunction. The core vision is to empower men to address their most intimate health issues through guided, CE-certified programs. The primary service offered by Regimen is an online program that includes self-assessment tools and expert guidance to improve erectile function. The market focus is on men seeking non-invasive, comprehensive treatments for erectile dysfunction.

Notable affiliated individuals include Dr. Wolf Beeck, who contributed to the development of the holistic program. Regimen's key achievement is being the first online program for long-term erectile dysfunction to receive CE certification, signifying compliance with European health, safety, and environmental protection standards. The overall impact of Regimen lies in its innovative approach to treating erectile dysfunction, providing men with accessible, effective, and non-invasive therapeutic options.

Regimen - Similar Companies

Renalis logo

Renalis

renalis.health

Opt Health logo

Opt Health

getopt.com

Virtue logo

Virtue

virtue.io

RecoveryLink logo

RecoveryLink

Nonu logo

Nonu

nonucare.com

Wholistics.Health logo

Wholistics.Health

wholistics.health

Jeevam Health logo

Jeevam Health

jeevamhealth.com

Ella logo

Ella

Rthm logo

Rthm

rthm.com

Perx Health logo

Perx Health

perxhealth.com

Remedy Well logo

Remedy Well

Resiliens logo

Resiliens

resiliens.com

Plantable logo

Plantable

plantable.com

Vitality Rx logo

Vitality Rx

vitalityrx.com

metaMe Health logo

metaMe Health

metamehealth.com

Regimen - Quick Facts

Who are Regimen's competitors?

Companies similar to Regimen include Renalis, Opt Health, Virtue and RecoveryLink.

When was Regimen founded?

Regimen was founded in 2019.

Where is Regimen's headquarters located?

Regimen's headquarters is located in San Jose, CA, US.

How much has Regimen raised to-date?

As of Oct 5, 2021, Regimen has raised a total of $2.3M (USD).

How many employees does Regimen have?

Regimen has 29 employees as of Feb 4, 2024.

Regimen - Classification

Ownership
  • Venture Capital
Technology
  • HealthTech
  • Telemedicine
Geographic Exposure
  • Global
Revenue
  • Recurring
Main Product
  • Digital Therapeutics
Tags
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified